1. Home
  2. BNR vs PCLA Comparison

BNR vs PCLA Comparison

Compare BNR & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • PCLA
  • Stock Information
  • Founded
  • BNR 2014
  • PCLA 2008
  • Country
  • BNR China
  • PCLA Japan
  • Employees
  • BNR N/A
  • PCLA N/A
  • Industry
  • BNR Medical Specialities
  • PCLA Building Products
  • Sector
  • BNR Health Care
  • PCLA Consumer Discretionary
  • Exchange
  • BNR Nasdaq
  • PCLA Nasdaq
  • Market Cap
  • BNR 29.1M
  • PCLA 32.3M
  • IPO Year
  • BNR 2020
  • PCLA 2025
  • Fundamental
  • Price
  • BNR $3.23
  • PCLA $1.88
  • Analyst Decision
  • BNR
  • PCLA
  • Analyst Count
  • BNR 0
  • PCLA 0
  • Target Price
  • BNR N/A
  • PCLA N/A
  • AVG Volume (30 Days)
  • BNR 38.7K
  • PCLA 1.9M
  • Earning Date
  • BNR 06-06-2025
  • PCLA 01-01-0001
  • Dividend Yield
  • BNR N/A
  • PCLA N/A
  • EPS Growth
  • BNR N/A
  • PCLA N/A
  • EPS
  • BNR N/A
  • PCLA N/A
  • Revenue
  • BNR $72,112,038.00
  • PCLA $5,475,228.00
  • Revenue This Year
  • BNR $136.32
  • PCLA N/A
  • Revenue Next Year
  • BNR N/A
  • PCLA N/A
  • P/E Ratio
  • BNR N/A
  • PCLA N/A
  • Revenue Growth
  • BNR 0.53
  • PCLA 40.19
  • 52 Week Low
  • BNR $2.18
  • PCLA $0.37
  • 52 Week High
  • BNR $7.90
  • PCLA $9.80
  • Technical
  • Relative Strength Index (RSI)
  • BNR 49.06
  • PCLA N/A
  • Support Level
  • BNR $3.06
  • PCLA N/A
  • Resistance Level
  • BNR $3.50
  • PCLA N/A
  • Average True Range (ATR)
  • BNR 0.36
  • PCLA 0.00
  • MACD
  • BNR -0.04
  • PCLA 0.00
  • Stochastic Oscillator
  • BNR 15.79
  • PCLA 0.00

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

Share on Social Networks: